Baukelien van Triest

Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2018 · 599 citations · Full text

Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

Stephanie M. de Boer, Melanie Powell, Linda Mileshkin et al. · The Lancet Oncology · 2019 · 432 citations · Full text

A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric Outcomes

Danny Y. Song, Klaus Herfarth, Matthias Uhl et al. · International Journal of Radiation Oncology*Biology*Physics · 2013 · 149 citations

Urology, Radiation Medicine, Radiation Therapy +7

Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines.

Baukelien van Triest, Herbert M. Pinedo, Yvette van Hensbergen et al. · PubMed · 1999 · 145 citations

Pathology, Thymidylate Synthase, Pharmacotherapy +16

The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy

Sophie R. de Mol van Otterloo, John P. Christodouleas, Erwin L. A. Blezer et al. · Frontiers in Oncology · 2020 · 136 citations · Full text